Smoking prevalence describes how common smoking is within a defined population and time period. Studies often find higher rates among people with schizophrenia than in the general population, but estimates differ across countries, services and…Continue Reading
Smoking increases risks of cardiovascular disease, respiratory illness and several cancers. These risks remain relevant for people with schizophrenia and contribute to preventable physical health burden. Existing psychiatric symptoms do not reduce the value of…Continue Reading
Components of tobacco smoke can induce metabolic enzymes, particularly CYP1A2, which affects medicines including clozapine and olanzapine. Smoking can therefore increase clearance and reduce exposure compared with otherwise similar circumstances. Reducing or stopping smoking can…Continue Reading
Smoking cessation support combines attention to nicotine dependence, habits and the person’s circumstances. Options can include behavioural support and appropriate cessation medicines, chosen with regard to mental and physical health. A previous unsuccessful attempt does…Continue Reading
Nicotine dependence involves adaptations that make continued nicotine use reinforcing and stopping uncomfortable. Cravings, irritability, concentration difficulty and other withdrawal experiences can maintain smoking. In schizophrenia, these effects may interact with symptoms, routines and social…Continue Reading